Aaron Kantoff - 24 Oct 2025 Form 4 Insider Report for Tourmaline Bio, Inc. (TRML)

Role
Director
Signature
/s/ Brad Middlekauff, Attorney-in-Fact
Issuer symbol
TRML
Transactions as of
24 Oct 2025
Net transactions value
$0
Form type
4
Filing time
24 Oct 2025, 18:10:19 UTC
Previous filing
09 Sep 2025
Next filing
28 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KANTOFF AARON Director C/O TOURMALINE BIO, INC., 27 WEST 24TH STREET, SUITE 702, NEW YORK /s/ Brad Middlekauff, Attorney-in-Fact 24 Oct 2025 0001862734

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRML Common Stock Gift $0 -5,000 -5.4% $0.000000 88,281 24 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares donated to a donor-advised fund, which will use the gifted shares for charitable purposes.